tradingkey.logo
tradingkey.logo
Suchen

Baxter International Inc

BAX
Zur Watchlist hinzufügen
21.550USD
+0.510+2.42%
Handelsschluss 06/25, 16:00ETKurse um 15 Minuten verzögert
11.13BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Baxter International Inc Unternehmen

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Baxter International Inc Informationen

BörsenkürzelBAX
Name des UnternehmensBaxter International Inc
IPO-datumJun 20, 2097
CEOHider (Andrew P)
Anzahl der mitarbeiter38000
WertpapierartOrdinary Share
GeschäftsjahresendeJun 20
AddresseOne Baxter Parkway
StadtDEERFIELD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl60015
Telefon12249482000
Websitehttps://www.baxter.com/
BörsenkürzelBAX
IPO-datumJun 20, 2097
CEOHider (Andrew P)

Führungskräfte von Baxter International Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
28.89K
+44.43%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
23.66K
+54.26%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
20.92K
+61.36%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Baxter International Inc?

Die fünf größten Anteilseigner von Baxter International Inc sind: Mr. Andrew P. Hider

Wie viele Institutionen halten Anteile an Baxter International Inc (BAX)?

Mit Stand vom 2026Q1 halten 1767 Institutionen Anteile an Baxter International Inc, mit einem Gesamtmarktwert von etwa 557.84M, was 108.01% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -45350754.00 gestiegen.

Was ist die größte Einnahmequelle von Baxter International Inc?

Am 2026Q1 erzielte das Geschäft mit Infusion Therapies and Technologies für Baxter International Inc den höchsten Umsatz in Höhe von 4.10B, was 36.47% des Gesamtumsatzes entspricht.
KeyAI